International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.09 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 1,554 shares.
International Stem Cell Trading Down 4.3 %
The company has a fifty day moving average price of $0.11 and a two-hundred day moving average price of $0.09. The firm has a market capitalization of $880,440.00, a price-to-earnings ratio of -1.38 and a beta of 0.05.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- Investing in the High PE Growth Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Airline Stocks – Top Airline Stocks to Buy Now
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Where Do I Find 52-Week Highs and Lows?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
